The Role of Clinical Observation: Red Flag 1 — Cardiomyopathies and Skeletal Muscle Involvement

[1]  L. Féasson,et al.  A novel CRYAB mutation resulting in multisystemic disease , 2012, Neuromuscular Disorders.

[2]  J. Schessl,et al.  The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy , 2010, Neuromuscular Disorders.

[3]  W. Boelens,et al.  Crystal structures of alpha-crystallin domain dimers of alphaB-crystallin and Hsp20. , 2009, Journal of molecular biology.

[4]  F. Muntoni,et al.  Mutation in BAG3 causes severe dominant childhood muscular dystrophy , 2008, Annals of neurology.

[5]  D. Zipes,et al.  Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. , 2008, The New England journal of medicine.

[6]  L. Mestroni,et al.  Genetics of dilated cardiomyopathy conduction disease , 2007 .

[7]  Anne L. Taylor,et al.  Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial , 2007, Circulation.

[8]  K. Campbell,et al.  C‐terminal titin deletions cause a novel early‐onset myopathy with fatal cardiomyopathy , 2007, Annals of neurology.

[9]  C. Long,et al.  Prevalence of Desmin Mutations in Dilated Cardiomyopathy , 2007, Circulation.

[10]  K. Campbell,et al.  Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness , 2006, Annals of neurology.

[11]  E. Arbustini,et al.  alphaB-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands. , 2006, Biochemical and biophysical research communications.

[12]  F. Tesson,et al.  Lamin A/C and cardiac diseases , 2006, Current opinion in cardiology.

[13]  J. Belmont,et al.  Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy , 2005, Circulation.

[14]  K. Hayashi,et al.  High Incidence of Sudden Cardiac Death With Conduction Disturbances and Atrial Cardiomyopathy Caused by a Nonsense Mutation in the STA Gene , 2005, Circulation.

[15]  E. McNally,et al.  Therapy Insight: cardiovascular complications associated with muscular dystrophies , 2005, Nature Clinical Practice Cardiovascular Medicine.

[16]  Andrew G Engel,et al.  Mutations in ZASP define a novel form of muscular dystrophy in humans , 2005, Annals of neurology.

[17]  M. Laakso,et al.  A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy. , 2004, European heart journal.

[18]  E. McNally,et al.  The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.

[19]  Andrew G Engel,et al.  Mutations in myotilin cause myofibrillar myopathy , 2004, Neurology.

[20]  Qiang Zhou,et al.  A Cypher/ZASP Mutation Associated with Dilated Cardiomyopathy Alters the Binding Affinity to Protein Kinase C* , 2004, Journal of Biological Chemistry.

[21]  G. Valle,et al.  Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. , 2003, Journal of the American College of Cardiology.

[22]  Wei Huang,et al.  &agr;B-Crystallin Modulates Protein Aggregation of Abnormal Desmin , 2003, Circulation research.

[23]  M. Komajda,et al.  Mutational analysis of the β‐ and δ‐sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy , 2003 .

[24]  L. Mestroni,et al.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. , 2003, Journal of the American College of Cardiology.

[25]  A. Cohen,et al.  A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. , 2003, The Journal of clinical endocrinology and metabolism.

[26]  P. Reiss,et al.  Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. , 2002, Neurology.

[27]  John Atherton,et al.  Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy , 2002, Nature Genetics.

[28]  J. Towbin,et al.  Mutations in the Human δ-Sarcoglycan Gene in Familial and Sporadic Dilated Cardiomyopathy, a Disease of the Cytoskeleton and Sarcolemma , 2000 .

[29]  J. Gilbert,et al.  Myotilin is mutated in limb girdle muscular dystrophy 1A. , 2000, Human molecular genetics.

[30]  L. Tavazzi,et al.  Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[31]  S. Bione,et al.  Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. , 2000, American journal of human genetics.

[32]  M. Dalakas,et al.  Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. , 2000, The New England journal of medicine.

[33]  L. Mestroni,et al.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. , 2000, Circulation.

[34]  T. Negri,et al.  Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations , 2000, Journal of medical genetics.

[35]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[36]  M Hiroe,et al.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. , 1999, Biochemical and biophysical research communications.

[37]  P. Burch,et al.  Desmin mutation responsible for idiopathic dilated cardiomyopathy. , 1999, Circulation.

[38]  J. Dean,et al.  Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series , 1999, Heart.

[39]  E. Hoffman,et al.  Heart involvement in muscular dystrophies due to sarcoglycan gene mutations , 1999, Muscle & nerve.

[40]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[41]  C. de Toma,et al.  Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy , 1998, Neurology.

[42]  A. Giese,et al.  Cardiac involvement in proximal myotonic myopathy , 1998, Heart.

[43]  L. Cartegni,et al.  Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy. , 1997, Human molecular genetics.

[44]  G. Danieli,et al.  Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.

[45]  S. di Somma,et al.  Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. , 1996, JAMA.

[46]  L. Mestroni,et al.  A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. , 1996, Human molecular genetics.

[47]  E. Bertini,et al.  Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy , 1993, Neurology.

[48]  R. Hetzer,et al.  Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[49]  Shin-ichiro Nishiyama,et al.  Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles. , 1993, Japanese circulation journal.

[50]  M. Davies,et al.  Primary restrictive cardiomyopathy: clinical and pathologic characteristics. , 1991, Journal of the American College of Cardiology.

[51]  E. Shen,et al.  Facioscapulohumeral muscular dystrophy and recurrent pacemaker lead dislodgement. , 1991, American heart journal.

[52]  M. Ōsawa,et al.  Fukuyama Type Congenital Progressive Muscular Dystrophy , 1991, Acta paediatrica Japonica : Overseas edition.

[53]  P. Poole‐Wilson,et al.  Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. , 1990, British heart journal.

[54]  M. Yoshioka,et al.  Follow up study of cardiac involvement in Emery-Dreifuss muscular dystrophy. , 1989, Archives of disease in childhood.

[55]  J. Miller,et al.  Duchenne muscular dystrophy , 1989, Neurology.

[56]  K. Miura,et al.  CONGENITAL MUSCULAR DYSTROPHY OF THE FUKUYAMA TYPE (FCMD) WITH SEVERE MYOCARDIAL FIBROSIS: A Case Report with Postmortem Angiography , 1987, Acta pathologica japonica.

[57]  F. Dreifuss,et al.  Unusual type of benign X linked muscular dystrophy , 1966, Journal of Neurology, Neurosurgery & Psychiatry.